Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Anesth Analg ; 78(1): 37-45, 1994 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8267178

RESUMO

Epidural analgesia combined with general anesthesia may improve cardiac function and reduce the work of the heart by decreasing the rate pressure product. However, the effect of this combined technique has not been studied in the presence of severe coronary artery stenosis. Therefore, we investigated epidural analgesia combined with general anesthesia in a swine model with a tight coronary artery stenosis. The coronary stenosis placed around the proximal left anterior descending coronary artery (LAD) allowed normal blood flow at rest but only minimum hyperemia in response to the coronary dilator, adenosine. To accomplish an extensive sympathetic block, we injected enough bupivacaine 0.5% into the lumbar epidural space to reach at least the level of the first thoracic vertebra (T1). Epidural catheter position was verified by fluoroscopy. Hemodynamic changes, LAD myocardial blood flow, and regional myocardial wall thickening were measured. Fifteen minutes after the injection of bupivacaine, systolic and diastolic blood pressure decreased 24.1% and 26%, respectively, cardiac output decreased 25.6%, and mean coronary blood flow decreased 42%, compared to the saline control. Myocardial wall thickening in the LAD bed decreased 31%, although it remained unchanged in the normal myocardium. Epidural bupivacaine added to general anesthesia resulted in moderate hypotension. Distal to the coronary stenosis was a moderate decrease in regional myocardial function and a severe reduction in blood flow.


Assuntos
Anestesia Epidural/efeitos adversos , Anestesia Geral/efeitos adversos , Doença das Coronárias/complicações , Isquemia Miocárdica/etiologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Bupivacaína , Circulação Coronária/efeitos dos fármacos , Doença das Coronárias/fisiopatologia , Depressão Química , Modelos Animais de Doenças , Coração/efeitos dos fármacos , Coração/fisiologia , Frequência Cardíaca/efeitos dos fármacos , Injeções Epidurais , Masculino , Isquemia Miocárdica/induzido quimicamente , Isquemia Miocárdica/fisiopatologia , Suínos
2.
J Cardiothorac Anesth ; 3(5): 532-5, 1989 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-2485220

RESUMO

The arrhythmogenic threshold was investigated during acute and chronic hypokalemia under halothane anesthesia with an epinephrine challenge in the rat model. It was hypothesized that in the setting of severe hypokalemia, general anesthesia would be arrhythmogenic and would be exaggerated with increased levels of catecholamines. Rats were divided into four groups as follows: normokalemic control (group I, n = 10), acute hypokalemia with furosemide (group II, n = 16), acute hypokalemia with hyperventilation (group III, n = 18), and chronic hypokalemia induced by a low potassium (K+) diet (group IV, n = 22). There were no significant differences (P less than .05) in baseline K+ and arterial blood gases among the four groups. There was a significant difference between groups I and II and groups I and IV (P less than 0.05) in serum K+ values after the low K+ diet, but no differences were observed between groups II and IV or groups I and III in serum K+ levels. There was no significant difference in myocardial tissue K+ among the four groups. There was a significant difference in the arrhythmic dose of epinephrine among the four groups (P less than 0.05). Acute hypokalemia was more prone to dysrhythmias than chronic hypokalemia. However, compared with control, acute and chronic hypokalemia groups were resistant to dysrhythmias is probably based on compensatory mechanisms. The heart seems more resistant to K+ changes than skeletal muscle. This resistance is associated with compensation by the cardiac muscle sodium pump in the face of K+ depletion. Hypokalemia per se did not increase the incidence of dysrhythmias under halothane anesthesia in rats.


Assuntos
Anestesia por Inalação , Arritmias Cardíacas/etiologia , Halotano , Hipopotassemia/complicações , Doença Aguda , Animais , Arritmias Cardíacas/fisiopatologia , Complexos Cardíacos Prematuros/etiologia , Complexos Cardíacos Prematuros/fisiopatologia , Doença Crônica , Epinefrina/farmacologia , Furosemida/efeitos adversos , Hiperventilação/complicações , Hipopotassemia/etiologia , Hipopotassemia/fisiopatologia , Masculino , Miocárdio/química , Potássio/análise , Potássio/sangue , Deficiência de Potássio/complicações , Ratos , Ratos Endogâmicos
3.
J Cardiothorac Anesth ; 2(2): 194-203, 1988 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17171912

RESUMO

The present study was designed to determine if infarct size under halothane anesthesia could be reduced by increasing the pressure gradient across the collateral vascular bed, thereby increasing flow within the occluded vascular bed. Forty-nine mongrel dogs were anesthetized with halothane under identical physiologic conditions with the exception of systemic arterial blood pressure. The control group of 18 animals anesthetized with halothane was compared to two experimental groups. In one group of 15 dogs, the mean systemic pressure was raised 25% above control with phenylephrine (BP25). In the second group of 15 dogs, systemic pressure was raised 50% above control (BP50). Adjacent marginal branches of the left circumflex coronary artery were ligated for 90 minutes followed by 90 minutes of reflow. The area of the occluded vascular bed was similar in all groups, but the area of infarction as a percentage of the occluded vascular bed was reduced from 47.7 +/- 4.7% to 25.4 +/- 4.3% in the BP25 group (P < or = .05 v control) and to 33.1 +/- 5.0% in the BP50 group. Flow measurements using microspheres showed a larger zone of ischemic tissue receiving adequate residual flow in the BP25 and BP50 groups compared to the control. It is concluded that infarct size during halothane anesthesia in the dog can be reduced by increasing systemic blood pressure with phenylephrine.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Circulação Coronária/efeitos dos fármacos , Halotano/administração & dosagem , Infarto do Miocárdio/prevenção & controle , Isquemia Miocárdica/prevenção & controle , Fenilefrina/farmacologia , Análise de Variância , Anestésicos Inalatórios/administração & dosagem , Animais , Vasos Coronários/fisiopatologia , Modelos Animais de Doenças , Cães , Frequência Cardíaca/efeitos dos fármacos , Masculino , Infarto do Miocárdio/patologia , Infarto do Miocárdio/fisiopatologia , Isquemia Miocárdica/patologia , Isquemia Miocárdica/fisiopatologia , Miocárdio/patologia , Fatores de Tempo , Vasoconstritores/farmacologia
4.
Anesthesiology ; 68(1): 68-72, 1988 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-3337391

RESUMO

Using the chronic maternal-fetal sheep preparation, nine pregnant ewes were studied to determine the effects of intravenous dantrolene sodium on maternal and fetal physiology, with particular reference to its placental passage, and its effects on uterine blood flow and uterine tone. Two doses of dantrolene sodium were studied: 1.2 mg/kg and 2.4 mg/kg. After 2.4 mg/kg, maternal cardiac output increased 29% (P less than 0.05) after 1 min and returned to normal after 30 min. Maternal mean arterial pressure increased 13% after 1 min and remained significantly elevated (P less than 0.01) for 3 h. No significant changes (P greater than 0.05) were observed in maternal heart rate, uterine artery blood flow, or central venous pressure. Maternal arterial pH declined from 7.42 to 7.39 (P less than 0.01) after 1 min and returned to baseline values after 10 min. Fetal heart rate decreased 24% (P less than 0.01) after 3 min and returned to normal after 10 min; the mean fetal arterial pressure remained unchanged (P greater than 0.05). Fetal arterial pH declined from 7.29 to 7.27 (P less than 0.05) after 1 min and remained significantly decreased for 120 min. Similar changes of lesser magnitude and shorter duration were seen following the 1.2 mg/kg dose. Maternal levels of dantrolene were less than 3 micrograms/ml. Although an equilibrium between maternal and fetal plasma dantrolene concentrations was apparent at 5 min, the fetal levels of dantrolene were approximately 10% of the mother's. The results indicate that the administration of intravenous dantrolene at 1.2 mg/kg or 2.4 mg/kg has no clinically significant adverse effect on mother or fetus in the sheep model.


Assuntos
Dantroleno/farmacologia , Hemodinâmica/efeitos dos fármacos , Troca Materno-Fetal , Equilíbrio Ácido-Base/efeitos dos fármacos , Animais , Dantroleno/metabolismo , Feminino , Feto/efeitos dos fármacos , Feto/fisiologia , Gravidez , Ovinos
5.
Basic Res Cardiol ; 80(3): 291-302, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-4026787

RESUMO

We investigated the effects of three anesthetics on the size of myocardial infarction and on blood flow distribution within the myocardial wall. Myocardial infarcts were induced in 34 dogs by ligating a coronary artery for 90 minutes, and permitting reflow for 90 minutes. The anesthetics used were fentanyl, Na-pentobarbital, and halothane. Under halothane the mean blood pressure (BP) during coronary artery ligation was 113 +/- 2/82 +/- 2 mm Hg and the heart rate (HR) was 135 +/- 2/min. Under fentanyl, the BP was 143 +/- 3/91 +/- 2 mm Hg and HR 99 +/- 3/min. Under Na-pentobarbital, BP was 141 +/- 2/104 +/- 2 mm Hg and HR 146 +/- 2/min. A higher mean BP combined with a slower HR, as seen under fentanyl, was associated with the smallest infarct (24 +/- 8%). Low BP and higher HR, as seen under halothane, was associated with the largest infarct (51 +/- 5%). Na-pentobarbital, with a higher BP but also a faster HR, resulted in an infarct size of 32 +/- 5%. We conclude that a higher mean BP combined with a slower HR might favor the preservation of a larger mass of vulnerable myocardial tissue in a totally occluded coronary artery.


Assuntos
Circulação Coronária/efeitos dos fármacos , Fentanila/farmacologia , Halotano/farmacologia , Infarto do Miocárdio/patologia , Miocárdio/patologia , Pentobarbital/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Cães , Eletrocardiografia , Sistema de Condução Cardíaco/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Masculino , Necrose , Consumo de Oxigênio/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...